Skip to main content
Top
Published in: Reactions Weekly 1/2022

01-11-2022 | Paracetamol | Case report

Pertuzumab

Hypersensitivity reaction: case report

Published in: Reactions Weekly | Issue 1/2022

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literature
go back to reference Lemus Calderon JA, et al. Desensitization to Pertuzumab With a Positive Skin Test Result in a Mixed-Phenotype Hypersensitivity Reaction. Journal of Investigational Allergology and Clinical Immunology 32: 320-321, No. 4, 2022. Available from: URL: http://doi.org/10.18176/jiaci.0761 Lemus Calderon JA, et al. Desensitization to Pertuzumab With a Positive Skin Test Result in a Mixed-Phenotype Hypersensitivity Reaction. Journal of Investigational Allergology and Clinical Immunology 32: 320-321, No. 4, 2022. Available from: URL: http://​doi.​org/​10.​18176/​jiaci.​0761
Metadata
Title
Pertuzumab
Hypersensitivity reaction: case report
Publication date
01-11-2022
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2022
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-27287-2

Other articles of this Issue 1/2022

Reactions Weekly 1/2022 Go to the issue

Case report

Hyaluronic-acid

Case report

Imatinib

Case report

Infliximab